An open-label, randomized, single center study evaluating the efficacy and safety of Ivabradine or Metoprolol, or Ivabradine plus Metoprolol combination in patients with conduction abnormalities or Left Ventricular systolic dysfunction undergoing coronary artery bypass grafting or valvular replacement.

Trial Profile

An open-label, randomized, single center study evaluating the efficacy and safety of Ivabradine or Metoprolol, or Ivabradine plus Metoprolol combination in patients with conduction abnormalities or Left Ventricular systolic dysfunction undergoing coronary artery bypass grafting or valvular replacement.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Ivabradine; Metoprolol
  • Indications Bundle branch block; Conduction disorders; Heart block; Left ventricular dysfunction
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top